These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35218152)

  • 1. Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line.
    Yu Q; Aimaier R; Chung MH; Cui X; Li Y; Wang Z; Li Q
    Pigment Cell Melanoma Res; 2022 May; 35(3):356-368. PubMed ID: 35218152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
    Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi.
    Aimaier R; Chung M; Zhu H; Yu Q
    Exp Dermatol; 2022 Apr; 31(4):582-585. PubMed ID: 35020224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi.
    Rouillé T; Aractingi S; Kadlub N; Fraitag S; How-Kit A; Daunay A; Hivelin M; Moguelet P; Picard A; Fontaine RH; Guégan S
    J Invest Dermatol; 2019 Sep; 139(9):2004-2015.e13. PubMed ID: 31059696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition.
    El Zaoui I; Bucher M; Rimoldi D; Nicolas M; Kaya G; Pescini Gobert R; Bedoni N; Schalenbourg A; Sakina E; Zografos L; Leyvraz S; Riggi N; Rivolta C; Moulin AP
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2764-2772. PubMed ID: 31247083
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Bansal N; Das M; Chatterjee U; Mallick MG; Arora N; Mishra DK
    Indian J Pathol Microbiol; 2021; 64(2):402-405. PubMed ID: 33851646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial clustering of giant congenital melanocytic nevi.
    de Wijn RS; Zaal LH; Hennekam RC; van der Horst CM
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):906-13. PubMed ID: 19464972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of novel MUC16, MAP3K15 and ABCA1 mutation with giant congenital melanocytic nevus.
    Zhou R; Wang Q; Hou J; Wang D; Liang Y
    Hereditas; 2022 Sep; 159(1):33. PubMed ID: 36085074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of targeting RAS-ERK signaling in giant congenital melanocytic nevi.
    Yu Q; Wu M; Sheng L; Li Q; Xie F
    Am J Transl Res; 2018; 10(4):1184-1194. PubMed ID: 29736211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin of patients with large/giant congenital melanocytic nevi shows increased mast cells.
    Salgado CM; Silver RB; Bauer BS; Basu D; Schmitt L; Khakoo Y; Reyes-Múgica M
    Pediatr Dev Pathol; 2014; 17(3):198-203. PubMed ID: 24679055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
    Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
    Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
    Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
    J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor Vorinostat (SAHA) suppresses micropthalmia transcription factor expression and induces cell death in nevocytes from large/giant congenital melanocytic nevi.
    Basu D; Salgado CM; Bauer B; Hoehl RM; Moscinski CN; Schmitt L; Reyes-Múgica M
    Melanoma Res; 2021 Aug; 31(4):319-327. PubMed ID: 34054057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retrospective molecular analysis of large or giant congenital melanocytic nevi in a group of Polish children.
    Wertheim-Tysarowska K; Szczygielski O; Seliga K; Tysarowski A; Bal J; Michalak E; Rygiel AM; Sawicka E
    J Mother Child; 2021 Oct; 25(1):19-24. PubMed ID: 34643354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocutaneous melanocytosis (melanosis).
    Ruggieri M; Polizzi A; Catanzaro S; Bianco ML; Praticò AD; Di Rocco C
    Childs Nerv Syst; 2020 Oct; 36(10):2571-2596. PubMed ID: 33048248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant Congenital Melanocytic Nevi: An Update and Emerging Therapies.
    Meshram GG; Kaur N; Hura KS
    Case Rep Dermatol; 2018; 10(1):24-28. PubMed ID: 29515391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous skin reconstruction by combining epidermis and acellular dermal matrix tissue derived from the skin of giant congenital melanocytic nevi.
    Liem PH; Morimoto N; Ito R; Kawai K; Suzuki S
    J Artif Organs; 2013 Sep; 16(3):332-42. PubMed ID: 23644894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocyte Sonic Hedgehog Upregulation Drives the Development of Giant Congenital Nevi via Paracrine Endothelin-1 Secretion.
    Chitsazan A; Ferguson B; Villani R; Handoko HY; Mukhopadhyay P; Gabrielli B; Mooi WJ; Soyer HP; Lambie D; Khosrotehrani K; Morahan G; Walker GJ
    J Invest Dermatol; 2018 Apr; 138(4):893-902. PubMed ID: 29138054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
    Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
    J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.